Clinical trials have shown that GTS-21 intervention in patients with endotoxemia does not lead to substantial differences in the serum levels of the proinflammatory cytokines TNF-α and IL-6 compared to those in controls (72). Here, IL6 is linked to serum lipopolysaccharide activity.